On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

NetworkNewsBreaks – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) Inks Partnership Agreement with Kawacatoose First Nation

Company: Isodiol International Inc. (ISOLF)
Category: News

Isodiol International (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, recently announced that it has signed a partnership agreement with Kawacatoose First Nation (“KFN”). The two companies will collaborate to cultivate and manufacture high yielding CBD derived from industrial hemp. The companies also intend to explore additional economic opportunities in commercializing the hemp by-product into everyday finished goods. Per the terms of the agreement, KFN will provide up to 3,000 farmable acres of land, based on availability and subject to certain conditions being met by both parties on a cost-plus model. Additionally, the companies intend to assemble a co-op within Saskatchewan, providing economic benefit province wide. “This is another strong step taken by the company to expand our footprint in Canada. The company will have significant access to the highest quality CBD, as KFN will provide the labour necessary to maintain and improve the farmland. The company will also provide expert consultation and advice to KFN and the future Co-op on all cultivation methods and standards applicable to the crop to ensure we remain consistent among all of our family of brands,” Isodiol CEO Marcos Agramont stated in the news release.

To view the full press release, visit http://nnw.fm/bLdL7

About Isodiol International Inc.

Isodiol International Inc. engages in pharmaceutical grade phytochemical compounds and the manufacturing and development of CBD consumer products. Isodiol is the pioneer in the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products. Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe. For more information visit the company’s website at www.isodiol.com.

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217